CLINICAL IMMUNOLOGY
The influence of KIR gene presence/absence polymorphisms on the development of periodontal disease in smokers and non-smokers
Submission date: 2016-07-29
Final revision date: 2016-12-29
Acceptance date: 2016-12-30
Publication date: 2017-12-30
Cent Eur J Immunol 2017;42(4):347-353
KEYWORDS
ABSTRACT
Introduction: Periodontal diseases are highly prevalent inflammatory, multifactorial diseases. Smoking is one of the most important environmental risk factors for the development and severity of periodontal disease. Killer cell immunoglobulin-like receptors (KIRs) are members of the immunoglobulin (Ig) superfamily and play an essential role in the regulation of NK cell activity, allowing natural killer (NK) cells to sense and respond to human leukocyte antigen (HLA) class I. The aim of this study was to evaluate the influence of KIR gene presence/absence polymorphisms on the development of periodontal disease in smokers and non-smokers.
Material and methods: This study enrolled 400 Caucasian subjects (age range 25-69 years) from the West Pomeranian region of Poland. The subjects were categorized into four subgroups (smoking and non-smoking patients with periodontal disease; smoking and non-smoking subjects without periodontal disease – control subjects).
Results: The differences of KIR gene frequencies between non-smoking patients and non-smoking control subjects as well as smoking patients and control subjects were not statistically significant. In multivariate regression analysis advanced age of patients and smoking were independent factors associated with increased frequency of periodontal disease.
Conclusions: The results of this study suggest that the main factor associated with increased risk of periodontal disease is smoking, whereas KIR presence/absence polymorphism is not a significant factor involved in the pathogenesis of periodontal disease.
Material and methods: This study enrolled 400 Caucasian subjects (age range 25-69 years) from the West Pomeranian region of Poland. The subjects were categorized into four subgroups (smoking and non-smoking patients with periodontal disease; smoking and non-smoking subjects without periodontal disease – control subjects).
Results: The differences of KIR gene frequencies between non-smoking patients and non-smoking control subjects as well as smoking patients and control subjects were not statistically significant. In multivariate regression analysis advanced age of patients and smoking were independent factors associated with increased frequency of periodontal disease.
Conclusions: The results of this study suggest that the main factor associated with increased risk of periodontal disease is smoking, whereas KIR presence/absence polymorphism is not a significant factor involved in the pathogenesis of periodontal disease.
REFERENCES (51)
2.
Pihlstrom BL, Michalowicz BS, Johnson NW (2005): Periodontal diseases. Lancet 366: 1809-1820.
3.
Tarannum F, Faizuddin M (2012): Effect of gene polymorphisms on periodontal diseases. Indian J Hum Genet 18: 9-19.
4.
Offenbacher S (1996): Periodontal diseases: pathogenesis. Ann Periodontol 1: 821-878.
5.
Meisel P, Schwahn C, Gesch D, et al. (2004): Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol 75: 236-242.
6.
Corey LA, Nance WE, Hofstede P, Schenkein HA (1993): Self-reported periodontal disease in a Virginia twin population. J Periodontol 64: 1205-1208.
7.
Michalowicz BS, Diehl SR, Gunsolley JC, et al. (2000): Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 71: 1699-1707.
8.
Palmer RM, Wilson RF, Hasan AS, Scott DA (2005): Mechanisms of action of environmental factors – tobacco smoking. J Clin Periodontol 32: 180-195.
9.
Kocher T, Schwahn C, Gesch D, et al. (2005): Risk determinants of periodontal disease – an analysis of the Study of Health in Pomerania (SHIP 0). J Clin Periodontol 32: 59-67.
10.
Tymkiw KD, Thunell DH, Johnson GK, et al. (2011): Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. J Clin Periodontol 38: 219-228.
11.
Mach L, Bedanova H, Soucek M, et al. (2016): Tobacco smoking and cytokine levels in human epicardial adipose tissue: Impact of smoking cessation. Atherosclerosis 13: 37-42.
12.
Tollerud DJ, Brown LM, Blattner WA, et al. (1991): T cell subsets in healthy black smokers and nonsmokers. Evidence for ethnic group as an important response modifier. Am Rev Respir Dis 144 (3 Part 1): 612-616.
13.
Thielens A, Vivier E, Romagné F (2012): NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 24: 239-245.
14.
Hsu KC, Chida S, Geraghty DE, Dupont B (2002): The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 190: 40-52.
15.
Augusto DG (2016): The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined? Front Genet 28: 121.
16.
Moffett A, Colucci F (2015): Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol Rev 267: 283-297.
17.
Luszczek W, Majorczyk E, Nowak I, et al. (2006): Inhibitory and activatory KIR gene frequencies in the Polish population. Int J Immunogenet 33: 167-170.
18.
Augusto DG, Petzl-Erler ML (2015): KIR and HLA under pressure: evidences of coevolution across worldwide populations. Hum Genet 134: 929-940.
19.
Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS (2003): KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171: 3415-3425.
20.
Carrillo-Bustamante P, Keşmir C, de Boer RJ (2016): The evolution of natural killer cell receptors. Immunogenetics 68: 3-18.
21.
Vilches C, Parham P (2002): KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20: 217-251.
22.
Kikuchi T, Willis DL, Liu M, et al. (2005): Dendritic-NK cell interactions in P. gingivalis-specific responses. J Dent Res 84: 858-862.
23.
Wilensky A, Chaushu S, Shapira L (2015): The role of natural killer cells in periodontitis. Periodontology 69: 128-141.
24.
American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions (2015). J Periodontol 86: 835-838.
25.
Vilches C, Castańo J, Gómez-Lozano N, Estefanía E (2007): Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70: 415-422.
26.
Niepiekło-Miniewska W, Majorczyk E, Matusiak L, et al. (2013): Protective effect of the KIR2DS1 gene in atopic dermatitis. Gene 527: 594-600.
27.
Mazurek-Mochol M, Majorczyk E, Banach J, et al. (2014): Are KIR genes associated with clinical parameters in the course of periodontitis? Post Hig 68: 1145-1151.
28.
Hiby SE, Walker JJ, O’shaughnessy KM, et al. (2004): Combinationsof maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957-965.
29.
Wyganowska-Swiatkowska M, Nohawica MM (2015): Effect of tobacco smoking on human gingival and periodontal fibroblasts. A systematic review of literature. Przegl Lek 72: 158-160.
30.
Nagarajan R, Miller CS, Dawson III D, et al. (2017): Cross-talk between clinical and host-response parameters of periodontitis in smokers. J Periodontal Res 52: 342-352.
31.
Lanza E, Magan-Fernandez A, Bermejo B, et al. (2016): Complementary clinical effects of red complex bacteria on generalized periodontitis in a caucasian population. Oral Dis 22: 430-437.
32.
Gomes SC, Abascal CC, Haas AN, et al. (2015): Influence of supragingival biofilm control and smoking habit on Interleukin-1 concentration. Braz Oral Res 29: S1806-83242015000100302.
33.
Winning L, Patterson CC, Cullen KM, et al. (2015): The association between subgingival periodontal pathogens and systemic inflammation. J Clin Periodontol 42: 799-806.
34.
Velosa-Porras J, Escobar-Arregoces F, Latorre-Uriza C, et al. (2016): Association between periodontal disease and endothelial dysfunction in smoking patients. Acta Odontol Latinoam 29: 29-35.
35.
Souto GR, Queiroz-Junior CM, Costa FO, Mesquita RA (2014): Effect of smoking on immunity in human chronic periodontitis. Immunobiology 219: 909-915.
36.
Donaldson K, Brown GM, Drost E, et al. (1991): Does cigarette smoke enhance the proteolytic activity of neutrophils? Ann N Y Acad Sci 624: 325-327.
37.
Soder B, Jin LJ, Wickholm S (2002): Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 29: 384-391.
38.
Persson, L, Bergstrom J, Gustafsson A (2003): The effect of tobacco smoking on neutrophil activity following periodontal surgery. J Periodontol 74: 1475-1482.
39.
Sopori ML, Kozak W (1998): Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83: 148-156.
40.
Sopori ML, Kozak W, Savage SM, et al. (1998): Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23: 189-204.
41.
Yamazaki K, Ohsawa Y, Yoshie H (2001): Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases. Am J Pathol 158: 1391-1398.
42.
Nowak M, Krämer B, Haupt M, et al. (2013): Activation of invariant NK T cells in periodontitis lesions. J Immunol 190: 2282-2291.
43.
Krämer B, Kebschull M, Nowak M, et al. (2013): Role of the NK cell-activating receptor CRACC in periodontitis. Infect Immun 81: 690-696.
44.
Fujita S, Takahashi H, Okabe H, et al. (1992): Distribution of natural killer cells in periodontal diseases: an immunohistochemical study. J Periodontol 63: 686-689.
45.
Kopp W (1988): Density and localization of lymphocytes with natural-killer (NK) cell activity in periodontal biopsy specimens from patients with severe periodontitis. J Clin Periodontol 15: 595-600.
46.
Stelin S, Ramakrishan H, Talwar A, et al. (2009): Immunohistological analysis of CD1a langerhans cells and CD57 natural killer cells in healthy and diseased human gingival tissue: a comparative study. J Indian Soc Periodontol 13: 150-154.
47.
Cobb CM, Singla O, Feil PH, et al. (1989): Comparison of NK-cell (Leu-7+ and Leu-11b+) populations in clinically healthy gingiva, chronic gingivitis and chronic adult periodontitis. J Periodontal Res 24: 1-7.
48.
Hughes DA, Haslam PL, Townsend PJ, Turner-Warwick M (1985): Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clin Exp Immunol 61: 459-466.
49.
Meliska CJ, Stunkard ME, Gilbert DG, et al. (1995): Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol 95: 901-910.
50.
Meisel P, Heins G, Carlsson LE, et al. (2003): Impact of genetic polymorphisms on the smoking-related risk of periodontal disease: the population-based study SHIP. Tob Induc Dis 1: 197-206.
51.
Kuśnierczyk P (2013): Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol 4: 8.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
